Bajaj Healthcare Promoter Anil Champala Jain Acquires 2,000 Additional Equity Shares

1 min read     Updated on 13 Dec 2025, 12:05 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Anil Champala Jain, Managing Director of Bajaj Healthcare Limited, acquired 2,000 equity shares through open market transactions on December 10, 2025. This acquisition increased his total shareholding from 60.69% to 60.76%. The transaction was disclosed in compliance with SEBI regulations.

27153322

*this image is generated using AI for illustrative purposes only.

Bajaj HealthCare Limited has disclosed an acquisition by its promoter group member Anil Champala Jain, who serves as the company's Managing Director. The acquisition involves 2,000 equity shares purchased through open market transactions on December 10, 2025.

Acquisition Details

The disclosure, filed under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, provides details of the transaction and its impact on shareholding patterns.

Parameter Details
Acquirer Anil Champala Jain (Managing Director)
Shares Acquired 2,000 equity shares
Acquisition Mode Open Market Purchase
Transaction Date December 10, 2025
Disclosure Date December 12, 2025

Shareholding Pattern Changes

The acquisition has resulted in a marginal increase in Anil Champala Jain's shareholding in the company. The detailed shareholding comparison shows the impact of this transaction on his overall stake.

Shareholding Category Before Acquisition After Acquisition Change
Shares with Voting Rights 14,61,775 shares (46.28%) 14,63,775 shares (46.35%) +2,000 shares
Warrants/Convertible Securities 4,55,074 shares (14.41%) 4,55,074 shares (14.41%) No change
Total Holding 19,16,849 shares (60.69%) 19,18,849 shares (60.76%) +2,000 shares

Regulatory Compliance

The transaction demonstrates adherence to regulatory requirements, with the promoter group member fulfilling disclosure obligations under SEBI regulations. The acquisition represents an open market purchase by an existing promoter.

Company Information

Bajaj Healthcare Limited maintains its registered office at Bhoomi Velocity, Wagle Industrial Estate, Thane. The disclosure was formally communicated to stock exchanges as per regulatory requirements.

Historical Stock Returns for Bajaj HealthCare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.40%-4.02%-9.52%-24.73%-14.52%+10.51%
Bajaj HealthCare
View in Depthredirect
like15
dislike

Bajaj Healthcare Unveils Investor Presentation, Showcasing Strong Financial Position and Diverse Operations

1 min read     Updated on 08 Dec 2025, 08:20 AM
scanx
Reviewed by
Riya DScanX News Team
Overview

Bajaj Healthcare Limited (BHL) has released an investor presentation for its upcoming analyst and institutional investor meeting on December 08-09, 2025. The presentation outlines BHL's diverse operations across API manufacturing, formulations, alkaloid processing, and CDMO business, with a global reach to over 60 countries. Financial highlights include an 8.87% increase in total assets to ₹833.00 crore, a 67.46% rise in total equity to ₹466.20 crore, and a 20% growth in current assets to ₹485.40 crore. The meeting is expected to focus on performance across business verticals, global market presence, CDMO partnerships, financial strategies, and alkaloid processing operations.

26707836

*this image is generated using AI for illustrative purposes only.

Bajaj HealthCare Limited (BHL) has released an investor presentation for its upcoming analyst and institutional investor meeting, scheduled for December 08-09, 2025. The presentation highlights the company's operations across multiple business verticals and its financial position.

Diverse Business Operations

BHL's operations span across several key areas:

  1. API Manufacturing
  2. Formulations
  3. Alkaloid Processing
  4. CDMO (Contract Development and Manufacturing Organization) Business

The company has established a global presence, with its products reaching over 60 countries worldwide.

Financial Position

Based on the latest balance sheet data, Bajaj Healthcare demonstrates the following financial metrics:

Financial Metric Current Year (2025-03) 1 Year Ago (2024-03) Change
Total Assets ₹833.00 crore ₹765.10 crore 8.87%
Current Assets ₹485.40 crore ₹404.50 crore 20.00%
Fixed Assets ₹238.40 crore ₹252.80 crore -5.70%
Total Equity ₹466.20 crore ₹278.40 crore 67.46%
Current Liabilities ₹272.30 crore ₹402.10 crore -32.28%

The company has shown changes in its financial position over the past year:

  • Asset Growth: Total assets increased by 8.87% to ₹833.00 crore.
  • Equity: Total equity rose by 67.46%, reaching ₹466.20 crore.
  • Liquidity: Current assets grew by 20% while current liabilities decreased by 32.28%.
  • Fixed Assets: A slight decrease of 5.70% in fixed assets was observed.

Investor Meeting Focus

The upcoming analyst and institutional investor meeting may cover:

  1. Performance across different business verticals
  2. Global market presence
  3. CDMO partnerships and prospects
  4. Financial position and growth strategies
  5. Alkaloid processing operations and market potential

Investors and analysts will have the opportunity to gain insights into Bajaj Healthcare's operations, financial strategies, and outlook during the scheduled meeting.

Historical Stock Returns for Bajaj HealthCare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.40%-4.02%-9.52%-24.73%-14.52%+10.51%
Bajaj HealthCare
View in Depthredirect
like16
dislike
More News on Bajaj HealthCare
Explore Other Articles
401.10
-9.85
(-2.40%)